You can buy or sell BVXV and other stocks, options, and ETFs commission-free!
BiondVax Pharmaceuticals Ltd. American Depositary Shares, also called BiondVax Pharmaceuticals, is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. Read More It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel. The listed name for BVXV is BiondVax Pharmaceuticals Ltd. American Depositary Shares.
52 Week High
52 Week Low
— per share
Expected Nov 24, Pre-Market